康臣药业(01681.HK)10月16日耗资311.8万港元回购20万股
Core Viewpoint - 康臣药业 announced a share buyback plan, indicating a commitment to enhancing shareholder value through the repurchase of shares [1] Group 1 - 康臣药业 plans to repurchase 200,000 shares at a total cost of HKD 3.118 million [1] - The buyback is scheduled for October 16, 2025, reflecting the company's strategy to manage its capital effectively [1]